ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
3.700
-0.100 (-2.63%)
Apr 2, 2026, 9:44 AM EDT - Market open
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $470.06 million as of April 2, 2026. Its market cap has increased by 174.67% in one year.
Market Cap
470.06M
Enterprise Value
660.98M
1-Year Change
174.67%
Ranking
Category
Stock Price
$3.70
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $470.06M, a decrease of -76.99%. That is a compound annual growth rate of -22.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 482.77M | 10.40% |
| Dec 31, 2025 | 437.29M | 127.27% |
| Dec 31, 2024 | 192.41M | 43.49% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rigel Pharmaceuticals | 508.01M |
| Upstream Bio | 506.65M |
| 4D Molecular Therapeutics | 503.88M |
| Contineum Therapeutics | 502.17M |
| Fulcrum Therapeutics | 498.17M |
| Verastem | 487.48M |
| Larimar Therapeutics | 486.17M |
| Entrada Therapeutics | 485.28M |